Merck (MRK) Total Non-Current Liabilities (2016 - 2025)
Historic Total Non-Current Liabilities for Merck (MRK) over the last 15 years, with Q3 2025 value amounting to $70.0 billion.
- Merck's Total Non-Current Liabilities rose 923040.0% to $70.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $70.0 billion, marking a year-over-year increase of 923040.0%. This contributed to the annual value of $750.0 million for FY2023, which is 2500.0% up from last year.
- Latest data reveals that Merck reported Total Non-Current Liabilities of $70.0 billion as of Q3 2025, which was up 923040.0% from $61.4 billion recorded in Q2 2025.
- Merck's Total Non-Current Liabilities' 5-year high stood at $70.0 billion during Q3 2025, with a 5-year trough of $400.0 million in Q1 2021.
- Its 5-year average for Total Non-Current Liabilities is $12.5 billion, with a median of $600.0 million in 2022.
- Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 2982.46% in 2021, then surged by 923040.0% in 2025.
- Quarter analysis of 5 years shows Merck's Total Non-Current Liabilities stood at $400.0 million in 2021, then soared by 50.0% to $600.0 million in 2022, then grew by 25.0% to $750.0 million in 2023, then changed by 0.0% to $750.0 million in 2024, then skyrocketed by 9230.4% to $70.0 billion in 2025.
- Its Total Non-Current Liabilities was $70.0 billion in Q3 2025, compared to $61.4 billion in Q2 2025 and $60.1 billion in Q1 2025.